Synergy Health, a provider of specialist outsourced support services to health related markets in the UK and Ireland, Europe and the Middle East, Asia and Africa, has acquired BeamOne for an initial cash consideration of $35m.
BeamOne is a provider of outsourced, e-beam medical device sterilization services in the US. BeamOne has FDA approved sites in San Diego, California; Denver, Colorado; Lima, Ohio; Saxonburg, Pennsylvania; and a fifth site in Costa Rica.
The acquisition of BeamOne is Synergy’s first expansion into the US sterilization market.
BeamOne’s relationships with US based, global medical device manufacturers, should enable Synergy to deepen further its relationships and capture greater sterilization business for its operations in Asia, and in particular China.
Furthermore, the acquisition will provide a platform from which Synergy can start to research and develop the provision of its central sterilization services to American hospitals and healthcare providers.
BeamOne’s current executive and management groups will remain in place.
Glenn Thibault, formerly president and CEO of BeamOne, will be the CEO of Synergy’s new Americas Region and Glenn will join the Senior Executive Board.
This acquisition follows the acquisition in December 2010 of Gamma-Service Prodktbestrahlung, a German provider of gamma and e-beam sterilization services to the healthcare and industrial sectors.
The transaction enabled Synergy to add electron beam processing to the service offering in mainland Europe and provided entry to other markets in Eastern Europe.